Cargando…

ADAM17 in tumor associated leukocytes regulates inflammatory mediators and promotes mammary tumor formation

The presence of inflammatory cells within the tumor microenvironment has been tightly linked to mammary tumor formation and progression. Specifically, interactions between tumor cells and infiltrating macrophages can contribute to the generation of a pro-tumorigenic microenvironment. Understanding t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bohrer, Laura R., Chaffee, Thomas S., Chuntova, Pavlina, Brady, Nicholas J., Witschen, Patrice M., Kemp, Sarah E., Nelson, Andrew C., Walcheck, Bruce, Schwertfeger, Kathryn L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059114/ https://www.ncbi.nlm.nih.gov/pubmed/27738494 http://dx.doi.org/10.18632/genesandcancer.115

Ejemplares similares

Characterization of Hyaluronan Localization in the Developing Mammary Gland and Mammary Tumors
por: Witschen, Patrice M., et al.
Publicado: (2023)

Macrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast Cancer
por: Brady, Nicholas J., et al.
Publicado: (2016)

Leukocyte ADAM17 Regulates Acute Pulmonary Inflammation
por: Arndt, Patrick G., et al.
Publicado: (2011)

Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival
por: Farooqui, Mariya, et al.
Publicado: (2015)

Tissue-resident macrophages promote extracellular matrix homeostasis in the mammary gland stroma of nulliparous mice
por: Wang, Ying, et al.
Publicado: (2020)

Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer
por: Witschen, Patrice M., et al.
Publicado: (2020)

Erratum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers 2020, 12, 1325
por: Witschen, Patrice M., et al.
Publicado: (2020)

STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment
por: Jesser, Emily A., et al.
Publicado: (2021)

Ectodomain Shedding by ADAM17: Its Role in Neutrophil Recruitment and the Impairment of This Process during Sepsis
por: Mishra, Hemant K., et al.
Publicado: (2017)

Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation
por: Mishra, Hemant K., et al.
Publicado: (2021)

Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors
por: Bapat, Aditi S., et al.
Publicado: (2023)

Blocking ADAM17 Function with a Monoclonal Antibody Improves Sepsis Survival in a Murine Model of Polymicrobial Sepsis
por: Mishra, Hemant K., et al.
Publicado: (2020)

Author Correction: Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors
por: Bapat, Aditi S., et al.
Publicado: (2023)

Differential Surface Expression of ADAM10 and ADAM17 on Human T Lymphocytes and Tumor Cells
por: Ebsen, Henriette, et al.
Publicado: (2013)

STAT5 deletion in macrophages alters ductal elongation and branching during mammary gland development
por: Brady, Nicholas J., et al.
Publicado: (2017)

Immunomodulatory role of metalloproteinase ADAM17 in tumor development
por: Wang, Kai, et al.
Publicado: (2022)

Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK
por: Lofgren, Kristopher A, et al.
Publicado: (2011)

Sulforaphane Diminishes the Formation of Mammary Tumors in Rats Exposed to 17β-Estradiol
por: Palliyaguru, Dushani L., et al.
Publicado: (2020)

Identification of an ADAM17 Cleavage Region in Human CD16 (FcγRIII) and the Engineering of a Non-Cleavable Version of the Receptor in NK Cells
por: Jing, Yawu, et al.
Publicado: (2015)

Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes
por: Tsukamoto, Shokichi, et al.
Publicado: (2014)

An ADAM17-Neutralizing Antibody Reduces Inflammation and Mortality While Increasing Viral Burden in a COVID-19 Mouse Model
por: Hedges, Jodi F., et al.
Publicado: (2022)

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency
por: Dosch, Joseph, et al.
Publicado: (2017)

ADAM 17 endopeptidase
Publicado: (2009)

Downregulation of ADAM17 in pediatric immune thrombocytopenia impairs proplatelet formation
por: Wang, Qi, et al.
Publicado: (2022)

ADAM10 and ADAM17: New Players in Trastuzumab Resistance
por: Duffy, Michael J., et al.
Publicado: (2014)

ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis
por: Van Meenen, Dario, et al.
Publicado: (2022)

Fibroblast Growth Factor Receptor 1 Activation in Mammary Tumor Cells Promotes Macrophage Recruitment in a CX3CL1-Dependent Manner
por: Reed, Johanna R., et al.
Publicado: (2012)

Role of ADAM10 and ADAM17 in Regulating CD137 Function
por: Seidel, Jana, et al.
Publicado: (2021)

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
por: Dixon, Kate J., et al.
Publicado: (2021)

Lentiviral CRISPR-guided RNA library screening identified Adam17 as an upstream negative regulator of Procr in mammary epithelium
por: Wu, Ting, et al.
Publicado: (2021)

LRP1 shedding in human brain: roles of ADAM10 and ADAM17
por: Liu, Qiang, et al.
Publicado: (2009)

Upregulation of APP, ADAM10 and ADAM17 in the Denervated Mouse Dentate Gyrus
por: Del Turco, Domenico, et al.
Publicado: (2014)

Influence of Anoctamin-4 and -9 on ADAM10 and ADAM17 Sheddase Function
por: Leitzke, Sinje, et al.
Publicado: (2022)

Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris
por: Kugelmann, Daniela, et al.
Publicado: (2022)

Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia
por: Szalad, Alexandra, et al.
Publicado: (2009)

ADAM17 is required for EGF-R–induced intestinal tumors via IL-6 trans-signaling
por: Schmidt, Stefanie, et al.
Publicado: (2018)

The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth
por: Badenes, Marina, et al.
Publicado: (2023)

Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
por: Matthews, Alexandra L., et al.
Publicado: (2017)

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
por: Sahin, Umut, et al.
Publicado: (2004)

The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas
por: Oh, S.-T., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v6quin73977e60na6bofddhcoj